Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Anthem's (ANTM) Buyout to Offer Better Healthcare in Puerto Rico
by Zacks Equity Research
Anthem (ANTM) acquires subsidiaries of InnovaCare Health in a bid to facilitate improved health outcomes across Puerto Rico.
HCA Healthcare's (HCA) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings gain on the back of better revenues.
The Zacks Analyst Blog Highlights: NVIDIA, Verizon, AstraZeneca, Micron Technology and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Verizon, AstraZeneca, Micron Technology and Anthem
Top Stock Reports for NVIDIA, Verizon & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Verizon (VZ), and AstraZeneca (AZN).
Stock Market News for Jan 28, 2021
by Zacks Equity Research
U.S. stock markets closed sharply lower on Wednesday on the back of several weaker-than-expected quarterly earnings results
Anthem (ANTM) Q4 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results benefit from higher revenues stemming from robust Medicaid and Medicare businesses, partly offset by higher costs.
Anthem (ANTM) Misses Q4 Earnings Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of -1.17% and 2.25%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher (TMO) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Thermo Fisher's (TMO) Life-Science Solutions and Specialty Diagnostics segments are expected to have contributed, banking on COVID-19-led growing healthcare needs.
Anthem (ANTM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem (ANTM) is likely to have witnessed increased revenues and a rise in membership during Q4, offset by an escalating expense level.
Why is it Advisable to Hold on to Cigna (CI) Stock Now?
by Zacks Equity Research
Cigna (CI) looks poised to grow on the back of business rejig, which involves growing its healthcare business while lowering debt.
Zacks.com featured highlights include: Magna International, Huntsman, Anthem, Energy Transfer and CACI International
by Zacks Equity Research
Zacks.com featured highlights include: Magna International, Huntsman, Anthem, Energy Transfer and CACI International
Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings
by Zacks Equity Research
Within EPD, Abbott (ABT) is expected to have witnessed visible signs of rebound through Q4.
Pick These 5 Bargain Stocks With Exciting EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks MGA, HUN, ANTM, ET and CACI based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Is Anthem (ANTM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in Store for UnitedHealth (UNH) This Earnings Season?
by Zacks Equity Research
UnitedHealth's (UNH) earnings results are likely to reflect solid contribution from its segments, namely Healthcare and Optum, partly offset by higher claim costs.
UnitedHealth (UNH) Enhances Virtual Care for Better Outcomes
by Zacks Equity Research
UnitedHealth (UNH) introduces virtual care offerings and expands services to boost telehealth visits.
3 Stocks to Watch Amid Expected Growth in Telehealth Sector
by Zacks Equity Research
The telehealth sector seems poised to maintain its robust growth in the future owing to the convenience it provides, making it a good time to keep an eye on names like Teladoc Health (TDOC) and Anthem (ANTM)
4 HMO Stocks in Focus as Players Adapt to Changes in the Industry
by Zacks Equity Research
Changing political scenario, increased investments in technology, growing senior population carve a strong growth trajectory for players in the HMO industry.
Here's Why You Should Steer Clear of Centene (CNC) Stock Now
by Zacks Equity Research
Rising costs and poor financial leverage make Centene (CNC) an unattractive stock now.
UnitedHealth (UNH) to Buy Change Healthcare, Stock Gains
by Zacks Equity Research
UnitedHealth's (UNH) purchase of Change Healthcare, which will be combined with the company's subsegment OptumInsight, is likely to bolster the unit's capabilities.
Why Anthem (ANTM) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Anthem (ANTM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Molina Healthcare (MOH) Acquires Magellan Health's Unit
by Zacks Equity Research
Molina Healthcare (MOH) wraps up the buyout of Magellan Health's arm MCC to expand its presence and boost its capabilities.
Centene (CNC) to Buy Magellan Health for Better Medical Care
by Zacks Equity Research
Centene (CNC) to acquire Magellan Health for providing better healthcare to the most susceptible and underserved communities.
Cigna (CI) Divests to Deepen Focus on Healthcare, Repay Debt
by Zacks Equity Research
Cigna's (CI) sale of its non-health unit paves way for it to focus on its core business and make debt repayments.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on strategic initiatives and growing membership, Anthem (ANTM) holds potential to reap benefits for investors.